RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
about
Novel complex integrating mitochondria and the microtubular cytoskeleton with chromosome remodeling and tumor suppressor RASSF1 deduced by in silico homology analysis, interaction cloning in yeast, and colocalization in cultured cellsThe tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complexA cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylationRegulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous SystemEpigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectivesAberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell linesThe Ras-association domain family (RASSF) members and their role in human tumourigenesis.High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group studyIdentification of epigenetically regulated genes that predict patient outcome in neuroblastomaEpigenetic regulation of apoptosis and cell cycle in osteosarcomaQuantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.Methylation of the RASSF1A gene in human cancers.Promoter methylation status of Ras-association domain family members in pheochromocytoma.Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastomaIdentification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma.EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFRGenome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.3p21.3 tumor suppressor cluster: prospects for translational applications.SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinomaInvestigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.RhBMP-2 Activates Hippo Signaling through RASSF1 in Esophageal Cancer CellsRASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker.Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma.The connections between neural crest development and neuroblastoma.Molecular and genetic bases of neuroblastoma.The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.Mechanisms of neuroblastoma regressionEvaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma.GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma.Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.Frequent epigenetic inactivation of the SLIT2 gene in gliomas.Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.Spontaneous regression of neuroblastoma.RASSF1A promoter is highly methylated in primitive neuroectodermal tumors of the central nervous system.DNA methylation patterns in EBV-positive and EBV-negative Hodgkin lymphomas.Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancerGenome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions
P2860
Q24302341-908EB262-66A3-4437-88B4-5532651EFE06Q24306286-2AA6F81A-439A-4FFF-9560-F8C79CC4424DQ24801375-5FC8A0ED-3E72-420B-82FE-085C24D62D12Q26744719-4F22FE21-1784-42F7-BAB8-906F8E28CA31Q26999187-EC0BF16E-943E-4A83-9480-EE250479FF79Q28206870-25289B5D-FA1D-4639-85C1-CEA572F4C6AAQ31121564-C4F74DBC-232F-48D6-BBBB-0FAA9851CDB7Q33355806-D0FF9FB0-B82D-437A-A73C-FCEF3AE13047Q33390459-78143D27-D640-47CB-B441-73DEB0051766Q33818726-80769632-E88F-45C5-A362-45623A78C3C9Q34495498-DBD74695-C5E6-4188-8FCC-3160931D0091Q34681945-E327D5A5-0A3B-42BB-A489-338786ED50E9Q34835468-62460FE5-F1E7-4906-A72C-EFA9E0EE923FQ35099523-F370B102-B620-46C4-9014-801F25574CA4Q35126668-9A917103-1BB8-4C1A-9F8E-FFA17F92BE23Q36359339-0E42551E-5645-4139-B95E-12C2ECFA22F4Q36365753-F0657CF6-A3A0-4630-8458-61FF0950C604Q36378134-4D46FA0B-22DB-4B3E-9C98-B3CAE8AA5086Q36383883-B8185DF6-2564-4B0B-831C-433DAEF351C4Q36429393-15A53FBC-4E17-4DB5-8C93-5B2D0812F12EQ36694377-163ABF01-90C2-4E10-BE25-4CC38B60EAD8Q36696226-EFBFF094-E71E-4331-BB4F-C09ECF209BCDQ36941559-606DEFF5-120D-499A-9999-4678B6AE3972Q37081084-9F236520-0BA0-4559-A745-94895F01DC5FQ37113671-DF088E71-6E3C-4F3F-96B7-2600B21A2581Q37836006-4C22611E-7E57-4FF2-A182-B9CCE8074BC3Q38010376-6EE58475-4287-4ECE-9600-5C7592A5507AQ38070334-FE33D313-B288-4121-BCBB-465C02C6E058Q38261519-6B8AFB5A-CD3D-4135-AB59-FDEDAFB48AFBQ38290673-3879E60E-4351-4225-996A-9DFA16497646Q39449319-29867930-3FE4-4E78-AD6F-3ED5CBBA5988Q39986063-2FF3988D-E489-4E9B-886C-F70D61875E6EQ40595717-8D335B43-ACB9-4B9E-A3AC-597943C9F30BQ44526180-D87E089A-4E0D-42BD-A272-E0775228A263Q47445963-82A6AD38-3E53-42E4-8DF9-BE032DDB8261Q50156376-3765CAC7-1E15-406C-A80D-6EF39FB57D1DQ53525041-249C2B57-DC3E-477C-B548-70FD3E34D0B3Q53544854-1AA8A2E1-F981-43D4-AD97-38534C3BF89FQ58134450-1C976DAB-7079-4C97-960A-F1F22E0C4C2FQ58321447-29A79770-5F4B-4324-BA80-477D80EEAF10
P2860
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
RASSF1A promoter region CpG is ...... mas and neuroblastoma tumours.
@en
RASSF1A promoter region CpG is ...... mas and neuroblastoma tumours.
@nl
type
label
RASSF1A promoter region CpG is ...... mas and neuroblastoma tumours.
@en
RASSF1A promoter region CpG is ...... mas and neuroblastoma tumours.
@nl
prefLabel
RASSF1A promoter region CpG is ...... mas and neuroblastoma tumours.
@en
RASSF1A promoter region CpG is ...... mas and neuroblastoma tumours.
@nl
P2093
P2860
P50
P356
P1433
P1476
RASSF1A promoter region CpG is ...... mas and neuroblastoma tumours.
@en
P2093
Agathanggelou A
Neumann HP
Voutilainen R
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204968
P407
P577
2001-11-01T00:00:00Z
P5875
P6179
1003770571